MicroRNA expression profile of dexamethasone-induced human bone marrow-derived mesenchymal stem cells during osteogenic differentiation

Journal of Cellular Biochemistry

Volumn 115, Issue 10, 2014, Pages 1683-1691

  Li, Tao ^a   Li, Hongling ^b   Li, Tangping ^b   Fan, Junfen ^b   Zhao, Robert Chunhua ^b   Weng, Xisheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

DEXAMETHASONE; MARROW DERIVED STEM CELLS; MicroRNA PROFILE; OSTEOGENIC DIFFERENTIATION

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; DEXAMETHASONE; ENDOGLIN; HERMES ANTIGEN; HISTONE DEACETYLASE 4; MEMBRANE ANTIGEN; MICRO RNA 130A; MICRO RNA 140; MICRO RNA 199A; MICRO RNA 23A; MICRO RNA 320A; MICRO RNA 320B; MICRO RNA 320C; MICRO RNA 744; MICRORNA; MICRORNA 155; MICRORNA 21; MICRORNA 214; MICRORNA 22; MICRORNA 221; MICRORNA 26A; OSTEOGENIN; SMAD1 PROTEIN; SMAD5 PROTEIN; STAT5B PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX4; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; MESSENGER RNA; MIRN23 MICRORNA, HUMAN;

ADHERENT CELL; ADULT; ARTICLE; BIOINFORMATICS; BONE DEVELOPMENT; CELL CYCLE REGULATION; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CHINESE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN BONE MARROW DERIVED MESENCHYMAL STEM CELL; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MINERALIZATION; OSSIFICATION; OSTEOGENIC DIFFERENTIATION; PHENOTYPE; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL;

ADULT; ANTI-INFLAMMATORY AGENTS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOGENESIS; RNA, MESSENGER; UP-REGULATION;

EID: 84906078529     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24831     Document Type: Article

References (63)

1. Asano T, Takahashi KA, Fujioka M, Inoue S, Ueshima K, Hirata T, Okamoto M, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T,. 2004. Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 77: 220-225.
2. Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, Bertin T, Dawson BC, Munivez E, Tao J, Lee BH,. 2012. MiRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 21: 2991-3000.
3. Baglìo SR, Devescovi V, Granchi D, Baldini N,. 2013. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene 527: 321-331.
4. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD,. 2008. MicroRNAs: New regulators of immune cell development and function. Nat. Immunol 9: 839-845.
5. Bartel DP,. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC,. 2005. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332: 370-379.
7. Cárcamo-Orive I, Gaztelumendi A, Delgado J, Tejados N, Dorronsoro A, Fernández-Rueda J, Pennington DJ, Trigueros C,. 2010. Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 cross-talk. J Bone Miner Res 25: 2115-2125.
8. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP,. 2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94: 92-95.
9. Cheng AM, Byrom MW, Shelton J, Ford LP,. 2005. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297.
10. Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y, Fan Q, Ma B,. 2011. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 112: 1844-1856.
11. Goff LA, Boucher S, Ricupero CL, Fenstermacher S, Swerdel M, Chase LG, Adams CC, Chesnut J, Lakshmipathy U, Hart RP,. 2008. Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: Prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol 36: 1354-1369.
12. Han J, Yang T, Gao J, Wu J, Qiu X, Fan Q, Ma B,. 2010. Specific microRNA expression during chondrogenesis of human mesenchymal stem cells. Int J Mol Med 25: 377-384.
13. Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A,. 2012. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. JAMA 308: 2369-2379.
14. Hassan MQ, Gordon JAR, Beloti MM, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB,. 2010. A network connecting Runx2, SATB2, and the miR-23a-27a-24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 107: 19879-19884.
15. Huang J, Zhao L, Xing L, Chen D,. 2010. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28: 357-364.
16. Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, Li H, Han Q, Zhao RC,. 2012. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev 21: 2531-2540.
17. Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS,. 2006. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147: 5592-5599.
18. Joung YH, Lim EJ, Darvin P, Chung SC, Jang JW, Do Park K, Lee HK, Kim HS, Park T, Yang YM,. 2012. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs. PLoS ONE 7: e47477.
19. Joung YH, Lim EJ, Darvin P, Jang JW, Park KD, Lee HK, Kim HS, Cho BW, Park T, Chung S, Park JH, Yang YM,. 2013. Hwanggeumchal sorghum extract enhances BMP7 and GH signaling through the activation of Jak2/STAT5B in MC3T3-E1 osteoblastic cells. Mol Med Rep 8: 891-896.
20. Kim YJ, Bae SW, Yu SS, Bae YC, Jung JS,. 2009a. MiR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 24: 816-825.
21. Kim YJ, Hwang SJ, Bae YC, Jung JS,. 2009b. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27: 3093-3102.
22. Kitajima M, Shigematsu M, Ogawa K, Sugihara H, Hotokebuchi T,. 2007. Effects of glucocorticoid on adipocyte size in human bone marrow. Med Mol Morphol 40: 150-156.
23. Kloosterman WP, Plasterk RH,. 2006. The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
24. Kogianni G, Mann V, Ebetino F, Nuttall M, Nijweide P, Simpson H, Noble B,. 2004. Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci 75: 2879-2895.
25. Kokabu S, Gamer L, Cox K, Lowery J, Tsuji K, Raz R, Economides A, Katagiri T, Rosen V,. 2012. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol Endocrinol 26: 87-94.
26. Komori T,. 2010. Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol 658: 43-49.
27. Lakshmipathy U, Hart RP,. 2008. Concise review: MicroRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26: 356-363.
28. Kong KY, Owens KS, Rogers JH, Mullenix J, Velu CS, Grimes HL, Dahl R,. 2010. MIR-23A microRNA cluster inhibits B-cell development. Exp Hematol 38: 629-640.
29. Li B,. 2008. Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy. Endocr Metab Immune Disord Drug Targets 8: 208-219.
30. Li H, Qian W, Weng X, Wu Z, Li H, Zhuang Q, Feng B, Bian Y,. 2012. Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells. PLoS ONE 7: e37030.
31. Li H, Li T, Wang S, Wei J, Fan J, Li J, Han Q, Liao L, Shao C, Zhao RC,. 2013. MiR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res 10: 313-324.
32. Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L,. 2012. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol 31: 157-161.
33. Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML,. 2008. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 23: 287-295.
34. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, Kato Y, Takemoto F, Nakasa T, Yamashita S, Takada S, Lotz MK, Ueno-Kudo H, Asahara H,. 2010. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24: 1173-1185.
35. Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, Iwamoto Y,. 2002. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 30: 185-190.
36. Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda A, Amemiya T, Kondoh Y, Tashiro H, Okazaki Y,. 2008. MiR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 368: 267-272.
37. Nissen-Meyer LS, Jemtland R, Gautvik VT, Pedersen ME, Paro R, Fortunati D, Pierroz DD, Stadelmann VA, Reppe S, Reinholt FP, Del Fattore A, Rucci N, Teti A, Ferrari S, Gautvik KM,. 2007. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. J Cell Sci 120: 2785-2795.
38. Ochiai H, Okada S, Saito A, Hoshi K, Yamashita H, Takato T, Azuma T,. 2012. Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiation. J Biol Chem 287: 22654-22661.
39. Oskowitz AZ, Lu J, Penfornis P, Ylostalo J, McBride J, Flemington EK, Prockop DJ, Pochampally R,. 2008. Human multipotent stromal cells from bone marrow and microRNA: Regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci USA 105: 18372-18377.
40. Otsuru S, Hofmann TJ, Olson TS, Dominici M, Horwitz EM,. 2013. Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. Cytotherapy 15: 146-153.
41. Palmieri A, Pezzetti F, Brunelli G, Martinelli M, Lo Muzio L, Scarano A, Scapoli L, Arlotti M, Guerzoni L, Carinci F,. 2010. Anorganic bovine bone (Bio-Oss) regulates miRNA of osteoblast-like cells. Int J Periodontics Restorative Dent 30: 83-87.
42. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
43. Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David JP, Reichardt HM, Amling M, Schütz G, Tuckermann JP,. 2010. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 11: 517-531.
44. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M,. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
45. Reppe S, Rian E, Jemtland R, Olstad OK, Gautvik VT, Gautvik KM,. 2000. Sox-4 messenger RNA is expressed in the embryonic growth plate and regulated via the parathyroid hormone/parathyroid hormone-related protein receptor in osteoblast-like cells. J Bone Miner Res 15: 2402-2412.
46. Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, Force Aldred S, Fedorov Y,. 2009. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS ONE 4: e5605.
47. Séguin C, Kassis J, Busque L, Bestawros A, Theodoropoulos J, Alonso ML, Harvey EJ,. 2008. Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia. Rheumatology (Oxford) 47: 1151-1155.
48. Shimizu E, Selvamurugan N, Westendorf JJ, Olson EN, Partridge NC,. 2010. HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression. J Biol Chem 285: 9616-9626.
49. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J,. 2009. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28: 4065-4074.
50. Stefani G, Slack FJ,. 2008. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230.
51. Takano-Murakami R, Tokunaga K, Kondo N, Ito T, Kitahara H, Ito M, Endo N,. 2009. Glucocorticoid inhibits bone regeneration after osteonecrosis of the femoral head in aged female rats. Tohoku J Exp Med 217: 51-58.
52. Thomas M, Lieberman J, Lal A,. 2010. Desperately seeking microRNA targets. Nat Struct Mol Biol 17: 1169-1174.
53. Wang S, Qu X, Zhao RC,. 2012. Clinical applications of mesenchymal stem cells. J Hematol Oncol 5: 19.
54. Wojtowicz AM, Templeman KL, Hutmacher DW, Guldberg RE, Garcia AJ,. 2010. Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects. Tissue Eng A 16: 2795-2808.
55. Wu T, Xie M, Wang X, Jiang X, Li J, Huang H,. 2012. MiR-155 modulates TNF-α-inhibited osteogenic differentiation by targeting SOCS1 expression. Bone 51: 498-505.
56. Yang Z, Bian C, Zhou H, Huang S, Wang S, Liao L, Zhao RC,. 2011. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev 20: 259-267.
57. Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang X, Liu Y, Tang L, Ding Y, Jin Y,. 2013. Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res 28: 559-573.
58. Yin L, Li YB, Wang YS,. 2006. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: Mechanism of steroid-induced osteonecrosis. Chin Med J (Engl) 119: 581-588.
59. Zeng Y, Qu X, Li H, Huang S, Wang S, Xu Q, Lin R, Han Q, Li J, Zhao RC,. 2012. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett 586: 2375-2381.
60. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS,. 2011. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA 108: 9863-9868.
61. Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, Liu B, Yu X,. 2012. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone 50: 325-330.
62. Zheng H, Li W, Wang Y, Xie T, Cai Y, Wang Z, Jiang B,. 2013. MiR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer. Carcinogenesis 35: 173-183.
63. Zhou S,. 2011. TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem 112: 1651-1660.